Dr. RShatsky
banner
dr-rshatsky.bsky.social
Dr. RShatsky
@dr-rshatsky.bsky.social
Breast Cancer Medical Oncologist at UC San Diego 😎 specializing in TNBC, Lobular, MBC, germline mutation carrier clinical care and precision/personalized medicine| Mom of 2| My other half is EROncDoc 🥰 #BCSM #MedSky #OncSky
#medSky #OncSKy Oncology/Medical community on here are any of you considering leaving the country given the political climate? I don’t want to raise my kids in a dictatorship and it’s getting more and more hopeless here. Would love to hear people’s thoughts😔
April 9, 2025 at 4:11 PM
Reposted by Dr. RShatsky
New Journal for ImmunoTherapy of Cancer ( #JITC ) article: Fc-mediated immune stimulating, pro-inflammatory and antitumor effects of anti-HER2 IgE against HER2-expressing and trastuzumab-resistant tumors bit.ly/41wAsiY

#MedSky #OncSky #CanSky #cancer #research
March 18, 2025 at 1:28 PM
Reposted by Dr. RShatsky
wired.com WIRED @wired.com · Mar 17
A new type of vaccine based on mRNA technology is seen by many as a potential breakthrough in the fight against cancer.

We sat down with oncologist Lennard Lee to discuss why he hopes these vaccines will prove to be the “silver lining of the pandemic.”
Covid Vaccines Have Paved the Way for Cancer Vaccines
The mRNA technology behind coronavirus vaccines is now being used to create bespoke vaccines for cancer patients.
wrd.cm
March 18, 2025 at 1:32 PM
I found the puppies at Miami Breast and they made me soooo happy #MBCC25
March 8, 2025 at 9:23 PM
OK who’s joining me at Miami breast this week? Not excited about spending money in a state like Florida, but am excited to speak about management of breast cancer during pregnancy and getting pregnant after breast cancer!! #OncSKY #MedSky#CanSKY
March 2, 2025 at 7:52 PM
Reposted by Dr. RShatsky
📢 all🩺#oncology #bcsm #MedSky #OncSky

🎯#TNBC patient case CME w/ @dr-rshatsky.bsky.social y.social & @ptarantinomd.bsky.social

✍️Supported by an edu grant from Gilead Sciences
🆓 #CME info 🔗 bit.ly/tnbc_casesim
Provided by @bonumce.bsky.social

🖱️👇Scroll down to start
February 28, 2025 at 6:08 PM
February 24, 2025 at 12:57 AM
I spend my precious free time hiding from reality and enjoying every single moment I can with my family. Yesterday Er_OncDoc the kids a s I supported our beloved San Diego zoo! #MedSky
February 24, 2025 at 12:51 AM
Reposted by Dr. RShatsky
These weren’t lazy bureaucrats doing unimportant work. They were working hard, and often for less money than they could get in the private sector, on key life-saving public health programs.

They were fired to give more money to billionaires.

#DOGEkills

#medsky

www.propublica.org/article/trum...
They Worked to Prevent Death. The Trump Administration Fired Them.
Public health teams are being gutted, imperiling efforts to safeguard organ donation and prevent maternal and infant death. Many workers expressed fear at what would happen to the work they left behin...
www.propublica.org
February 23, 2025 at 11:59 PM
Reposted by Dr. RShatsky
Misinformation on social media is winning – scientists must adapt healthydebate.ca/2025/02/topi... via @healthydebate.bsky.social

"It’s not just about vaccines or pandemics – misinformation about ADHD, cancer treatments, weight loss, fertility & chronic disease management thrives online."
Misinformation on social media is winning – scientists must adapt or lose the battle - Healthy Debate
Scientists and health professionals must rethink how we communicate or risk further marginalization in the public discourse.
healthydebate.ca
February 5, 2025 at 3:23 PM
Reposted by Dr. RShatsky
Healthcare workers are very welcome in Canada.
#MedSky
February 5, 2025 at 9:23 PM
Reposted by Dr. RShatsky
Internal Medicine rounds are never “aggressively boring” with Dr. G. Watch the latest video in which @glaucomflecken.bsky.social summarizes the PICNIC trial: www.tiktok.com/@nejm.org/vi...

#MedSky
“To spice things up, I thought we could end rounds with a game show quiz!” Our latest video in our partnership with @drglaucomflecken explains the results of the PICNIC trial, which investigated wheth...
TikTok video by NEJM
www.tiktok.com
February 5, 2025 at 11:46 PM
Reposted by Dr. RShatsky
I am definitely burning the candle at both ends. Spoke at the USC breast symposium last weekend and speaking at the UCSD Binyatara conference this weekend. A friend did get a good pic or me wildly gesticulating last weekend though😆. This is my the SOC is not enough face!!! #CanSKy #MedSky
January 30, 2025 at 6:38 AM
Just when you thought your day (or month) couldn’t get any worse…. you pull a muscle in your neck…and well. It’s so much worse 😑. I’m not sure what this emoji I just found is supposed to be, but I think it’s what I need right now 💆🏼‍♀️
a cartoon of two cats laying next to each other with the words you giving me a neck and shoulder massage
ALT: a cartoon of two cats laying next to each other with the words you giving me a neck and shoulder massage
media.tenor.com
January 28, 2025 at 5:26 AM
Most mom’s in their mid 40’s invest in cute jeans and yoga pants for themselves. But when you’re an oncology nerd on the academic conference speaking circuit. It’s badass suits that make all the difference and my houndstooth game is strong. #Medsky #AcademicMedicine #CanSky #OncSky
January 24, 2025 at 4:36 AM
After all the experience I’ve had with Dato D’xd I JUST found out they named it Datroway. Why was that so hush hush for so long?? #MedSky #CanSky #OncSKy www.clinicaloncology.com/Solid-Tumors...
FDA Approves Datroway for Unresectable or Metastatic, HR-positive, HER2-negative Breast Cancer
The FDA has approved datopotamab deruxtecan-dlnk (Datroway, Daiichi Sankyo), a Trop-2−directed antibody and topoisomerase inhibitor conjugate, for adult ...
www.clinicaloncology.com
January 23, 2025 at 2:29 PM
Reading the news headlines is making me so ill I needed my bestie in bed tonight. Pray for your cancer researchers to keep their jobs amid the Trump administration freezing the NIH study section groups. #CanSky #OncSky #MedSky
January 23, 2025 at 4:28 AM
The new administration is here and I’m scared to look and find out what important life saving health measures are being cut each day. Yesterday was the plan to lower Medicare drug costs for seniors. What will tomorrow hold? #MedSky
January 22, 2025 at 1:59 PM
Posting this as a PSA. There seems to have been some article in the media about City of Hope’s Ivermectin phase 1 in TNBC. It has been open since 2021. Not looking good. Stop messaging your poor oncologist about this. It is not some miracle cure. #MedSky #CanSky
Also the entire cancer community somehow suddenly discovered a few old papers on ivermectin and are now flooding my inbox with requests for ivermectin. They site a phase 1 trial that has been open since 2021, but is totally negative and being shut down for lack of efficacy. #CanSky
two women are standing in a living room and one of them says that 's not how this works
ALT: two women are standing in a living room and one of them says that 's not how this works
media.tenor.com
January 16, 2025 at 4:29 AM
And after a long day of clinic and a inaugural BlueSky breast cancer chat I get home to this! I’m a lucky lady! ❤️ He looks better in it than I do for sure. #MedSky
January 15, 2025 at 3:14 AM
Reposted by Dr. RShatsky
19/20 #TumorBoardTuesday @dr-rshatsky.bsky.social
👉For instance: Feb 2024, ARV-471, an investigational, oral PROTAC studied in the phase 3 VERITAC-2 trial, received FDA fast-track designation.
www.pfizer.com/news/announc...
Arvinas and Pfizer’s Vepdegestrant (ARV-471) Receives FDA Fast Track Designation for the Treatment of Patients with ER+/HER2- Metastatic Breast Cancer | Pfizer
Vepdegestrant is an investigational PROteolysis Targeting Chimera (PROTAC®) protein degrader designed to target and degrade the estrogen receptor (ER) protein
www.pfizer.com
January 15, 2025 at 1:51 AM
Reposted by Dr. RShatsky
18/20 #TumorBoardTuesday @dr-rshatsky.bsky.social
Beyond SERDs/SERMs…novel endocrine therapies targeting other mechanisms in pipeline:
Proteolysis targeting chimeras (PROTACs), selective ER covalent antagonists, complete ER antagonists just to name a few!🤯
January 15, 2025 at 1:50 AM
Reposted by Dr. RShatsky
17/20 #TumorBoardTuesday @dr-rshatsky.bsky.social
Beyond EMBER-3, novel combinations with SERDs and SERMs also being evaluated with CDK4/6i
January 15, 2025 at 1:48 AM